Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Slørdal

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Clinical Pharmacology|March 20, 2010
Norwegian medical students' attitudes towards the pharmaceutical industryDordi Lea, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 24, 2003
[Heroin: a useful analgesic?]Håvard Furunes, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 9, 2005
[COX-2 inhibitors--one step forward and two steps back]Sigurd Evensen, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 16, 2006
[Generic drugs instead of brand drugs prescriptions--long overdue]Siri Nelson, Lars Slørdal, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 16, 2005
[Is not primum non nocere valid anymore?]Lars Slørdal, Sigurd Evensen, Olav Spigset
Journal of Evaluation in Clinical Practice|May 9, 2008
Effect of warnings in a medical journal on the use of orphenadrinePål Gjerden, Jørgen G Bramness, Lars Slørdal
Journal of Forensic Sciences|February 18, 2010
Death of a 10-month-old boy after exposure to ethylmorphineArne Helland, Christina V Isaksen, Lars Slørdal
European Journal of Clinical Pharmacology|June 4, 2010
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-upPål Gjerden, Lars Slørdal, Jørgen G Bramness
British Journal of Clinical Pharmacology|August 22, 2009
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrinePål Gjerden, Lars Slørdal, Jørgen G Bramness
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 22, 2012
[Conflicts of interest--an evidence-based approach]Lars Slørdal, Anne Elise Eggen, Tarjei Rygnestad
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Clinical Pharmacology|March 20, 2010
Norwegian medical students' attitudes towards the pharmaceutical industryDordi Lea, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 24, 2003
[Heroin: a useful analgesic?]Håvard Furunes, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 9, 2005
[COX-2 inhibitors--one step forward and two steps back]Sigurd Evensen, Olav Spigset, Lars Slørdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 16, 2006
[Generic drugs instead of brand drugs prescriptions--long overdue]Siri Nelson, Lars Slørdal, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 16, 2005
[Is not primum non nocere valid anymore?]Lars Slørdal, Sigurd Evensen, Olav Spigset
Journal of Evaluation in Clinical Practice|May 9, 2008
Effect of warnings in a medical journal on the use of orphenadrinePål Gjerden, Jørgen G Bramness, Lars Slørdal
Journal of Forensic Sciences|February 18, 2010
Death of a 10-month-old boy after exposure to ethylmorphineArne Helland, Christina V Isaksen, Lars Slørdal
European Journal of Clinical Pharmacology|June 4, 2010
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-upPål Gjerden, Lars Slørdal, Jørgen G Bramness
British Journal of Clinical Pharmacology|August 22, 2009
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrinePål Gjerden, Lars Slørdal, Jørgen G Bramness
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 22, 2012
[Conflicts of interest--an evidence-based approach]Lars Slørdal, Anne Elise Eggen, Tarjei Rygnestad
Pageof 13